Antithrombotic and profibrinolytic activities of isorhamnetin-3-O-galactoside and hyperoside

Food and Chemical Toxicology

Volumn 53, Issue , 2013, Pages 197-204

  Ku, Sae Kwang ^a   Kim, Tae Hoon ^a   Lee, Sangkyu ^b   Kim, Seong Min ^c   Bae, Jong Sup ^b  

^a Daegu Haany University   (South Korea)

^b Kyungpook National University   (South Korea)

^c Worcester Academy   (United States)

Author keywords

Coagulation cascade; Endothelium; Fibrinolysis; Isorhamnetin 3 O galactoside

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 10A; HEPARIN; HYPERIN; ISORHAMNETIN; ISORHAMNETIN 3 O GALACTOSIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTICOAGULATION; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG STRUCTURE; ENZYME ACTIVITY; FIBRIN POLYMERIZATION; FIBRINOLYSIS; HUMAN; HUMAN CELL; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PLASMA CONCENTRATION-TIME CURVE; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTHROMBIN TIME;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; ANTIOXIDANTS; CELL SURVIVAL; FACTOR XA; FIBRINOLYTIC AGENTS; GALACTOSIDES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICE; MICE, INBRED ICR; PARTIAL THROMBOPLASTIN TIME; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN TIME; QUERCETIN; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR-ALPHA;

OENANTHE JAVANICA;

EID: 84871755328     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.11.040     Document Type: Article

References (40)

1. Arts I.C., Sesink A.L., Faassen-Peters M., Hollman P.C. The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides. Br. J. Nutr. 2004, 91:841-847.
2. Bae J.S. Antithrombotic and profibrinolytic activities of phloroglucinol. Food Chem. Toxicol. 2011, 49:1572-1577.
3. Bae J.S., Rezaie A.R. Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand. Thromb. Haemost. 2008, 100:101-109.
4. Beutler J.A., Hamel E., Vlietinck A.J., Haemers A., Rajan P., Roitman J.N., Cardellina J.H., Boyd M.R. Structure-activity requirements for flavone cytotoxicity and binding to tubulin. J. Med. Chem. 1998, 41:2333-2338.
5. Davie E.W. Biochemical and molecular aspects of the coagulation cascade. Thromb. Haemost. 1995, 74:1-6.
6. Davie E.W., Fujikawa K., Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991, 30:10363-10370.
7. Dejana E., Callioni A., Quintana A., de Gaetano G. Bleeding time in laboratory animals. II - a comparison of different assay conditions in rats. Thromb. Res. 1979, 15:191-197.
8. Della Valle P., Crippa L., Garlando A.M., Pattarini E., Safa O., Vigano D'Angelo S., D'Angelo A. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Haematologica 1999, 84:1065-1074.
9. Esmon C.T. Role of coagulation inhibitors in inflammation. Thromb. Haemost. 2001, 86:51-56.
10. Furie B., Furie B.C. Thrombus formation in vivo. J. Clin. Invest. 2005, 115:3355-3362.
11. Ghosh S., Ezban M., Persson E., Pendurthi U., Hedner U., Rao L.V. Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface. J. Thromb. Haemost. 2007, 5:336-346.
12. Hamaguchi E., Takamura T., Shimizu A., Nagai Y. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells. J. Pharmacol. Exp. Ther. 2003, 307:987-994.
13. Han Y.Q., Huang Z.M., Yang X.B., Liu H.Z., Wu G.X. In vivo and in vitro anti-hepatitis B virus activity of total phenolics from Oenanthe javanica. J. Ethnopharmacol. 2008, 118:148-153.
14. Hosseinimehr S.J., Azadbakht M., Abadi A.J. Protective effect of hawthorn extract against genotoxicity induced by cyclophosphamide in mouse bone marrow cells. Environ. Toxicol. Pharmacol. 2008, 25:51-56.
15. Ji G., Yao X., Zang Z., Huang Z. Antiarrhythmic effect of Oenanthe javanica (Bl.) DC. injection. Zhongguo Zhong Yao Za Zhi 1990, 15(429-431):448.
16. Kim T.H., Ku S.K., Bae J.S. Antithrombotic and profibrinolytic activities of eckol and dieckol. J. Cell. Biochem. 2012, 113:2877-2883.
17. Li Y., Qian Z.J., Ryu B., Lee S.H., Kim M.M., Kim S.K. Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava. Bioorg. Med. Chem. 2009, 17:1963-1973.
18. Li Y.Q., Zhou F.C., Gao F., Bian J.S., Shan F. Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of alpha-glucosidase. J. Agric. Food Chem. 2009, 57:11463-11468.
19. Liu X., Wang D., Wang S.Y., Meng X.S., Zhang W.J., Ying X.X., Kang T.G. LC determination and pharmacokinetic study of hyperoside in rat plasma after intravenous administration. Yakugaku Zasshi 2010, 130:873-879.
20. Lopez S., Peiretti F., Bonardo B., Juhan-Vague I., Nalbone G. Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells. Atherosclerosis 2000, 152:359-366.
21. Ma C.J., Lee K.Y., Jeong E.J., Kim S.H., Park J., Choi Y.H., Kim Y.C., Sung S.H. Persicarin from water dropwort (Oenanthe javanica) protects primary cultured rat cortical cells from glutamate-induced neurotoxicity. Phytother. Res. 2010, 24:913-918.
22. Materska M. Quercetin and its derivatives: chemical structure and bioactivity. Pol. J. Food Nutr. Sci. 2008, 58:407-413.
23. Matsuda H., Morikawa T., Toguchida I., Yoshikawa M. Structural requirements of flavonoids and related compounds for aldose reductase inhibitory activity. Chem. Pharm. Bull. (Tokyo) 2002, 50:788-795.
24. Matsuda H., Wang T., Managi H., Yoshikawa M. Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg. Med. Chem. 2003, 11:5317-5323.
25. Monroe D.M., Hoffman M., Roberts H.R. Platelets and thrombin generation. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1381-1389.
26. Nowak P., Zbikowska H.M., Ponczek M., Kolodziejczyk J., Wachowicz B. Different vulnerability of fibrinogen subunits to oxidative/nitrative modifications induced by peroxynitrite: functional consequences. Thromb. Res. 2007, 121:163-174.
27. Olds R.J., Lane D.A., Mille B., Chowdhury V., Thein S.L. Antithrombin: the principal inhibitor of thrombin. Semin. Thromb. Hemost. 1994, 20:353-372.
28. Olson S.T., Bjork I. Regulation of thrombin activity by antithrombin and heparin. Semin. Thromb. Hemost. 1994, 20:373-409.
29. Park J.C., Yu Y.B., Lee J.H. Isolation of steroids and flavonoids from the herb of Oenanthe javanica DC. Korean J. Pharmacognosy 1993, 24:244-246.
30. Philip-Joet F., Alessi M.C., Philip-Joet C., Aillaud M., Barriere J.R., Arnaud A., Juhan-Vague I. Fibrinolytic and inflammatory processes in pleural effusions. Eur. Respir. J. 1995, 8:1352-1356.
31. Quinn C., Hill J., Hassouna H. A guide for diagnosis of patients with arterial and venous thrombosis. Clin. Lab. Sci. 2000, 13:229-238.
32. Radwan H.M., Nazif N.M., Abou-Setta L.M. Phytochemical investigation of Salicornia fruticosa (L.) and their biological activity. Res. J. Med. Med. Sci. 2007, 2:72-78.
33. Rao L.V., Rapaport S.I., Lorenzi M. Enhancement by human umbilical vein endothelial cells of factor Xa-catalyzed activation of factor VII. Blood 1988, 71:791-796.
34. Rice-Evans C.A., Miller N.J., Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 1996, 20:933-956.
35. Schleef R.R., Bevilacqua M.P., Sawdey M., Gimbrone M.A., Loskutoff D.J. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J. Biol. Chem. 1988, 263:5797-5803.
36. Seo W.H., Baek H.H. Identification of characteristic aroma-active compounds from water dropwort (Oenanthe javanica DC.). J. Agric. Food Chem. 2005, 53:6766-6770.
37. Sikorska M., Matlawska I. Kaempferol, isorhamnetin and their glycosides in the flowers of Asclepias syriaca L. Acta Pol. Pharm. 2001, 58:269-272.
38. Sugo T., Nakamikawa C., Tanabe S., Matsuda M. Activation of prothrombin by factor Xa bound to the membrane surface of human umbilical vein endothelial cells: its catalytic efficiency is similar to that of prothrombinase complex on platelets. J. Biochem. 1995, 117:244-250.
39. Tadera K., Minami Y., Takamatsu K., Matsuoka T. Inhibition of alpha-glucosidase and alpha-amylase by flavonoids. J. Nutr. Sci. Vitaminol. (Tokyo) 2006, 52:149-153.
40. Yang X.B., Huang Z.M., Cao W.B., Zheng M., Chen H.Y., Zhang J.Z. Antidiabetic effect of Oenanthe javanica flavone. Acta Pharmacol. Sin. 2000, 21:239-242.